CIDP_patient_vs_healthy_control

Profile details

Identifier: MTBLS5828_0001_00000001
Linked study: MTBLS5828 — Metabolic disorder and intestinal microflora dysbiosis in chronic inflammatory demyelinating polyradiculoneuropathy
Comparison: CIDP_patient vs healthy_control
Group A: Samples from patients diagnosed with CIDP.. Understanding the metabolic and microbiome differences in CIDP patients compared to healthy individuals.
Group B: Samples from healthy individuals serving as controls.. Provides a baseline to identify deviations in CIDP patients.
Total features tested: 610
Significant features: 205
p-value threshold: 0.05
Ratio threshold (upper): 1.5
Ratio threshold (lower): 1/1.5
Date created: 2025-09-26 00:00:00

Metabolite ID (InChI Key)	Name	Direction	Ratio	p-value
LGGHDPFKSSRQNS-UHFFFAOYSA-N	N-[2-[[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxyphenyl]quinoline-3-carboxamide	up	33.87	1.23e-21
HCFSGRMEEXUOSS-JXEXPEPMSA-N	medrogesterone	up	492.6	6e-10
WMHJCSAICLADIN-WYWSWGBSSA-N	(R)-4-(beta-D-Glucopyranosyloxy)-2,6,6-trimethyl-1-cyclohexene-1-carboxaldehyde	up	128.8	2.52e-12
HQMNCQVAMBCHCO-DJRRULDNSA-N	3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonanetetraenoic acid ethyl ester	up	144.9	5.22e-12
JIQSDJNLGMFGDV-VZUCSPMQSA-N	(E)-3-(2,4-dihydroxyphenyl)-1-[3-[5-(2,4-dihydroxyphenyl)-6-(5-hydroxy-2,2-dimethylchromene-6-carbonyl)-3-methylcyclohex-2-en-1-yl]-2,4-dihydroxyphenyl]prop-2-en-1-one	up	15.76	3.89e-19
KKADPXVIOXHVKN-UHFFFAOYSA-N	3-(4-HYDROXY-PHENYL)PYRUVIC ACID	up	34.82	1.23e-13
PDMUULPVBYQBBK-UHFFFAOYSA-N	—	up	20.83	3.72e-15
LNUSDHULQVPZFO-RYJVCDSQSA-N	10-(3'<i>R</i>,5'<i>R</i>-dihydroxy-6'<i>S</i>-methyl-(2<em>H</em>)-tetrahydropyran-2'-yloxy)-2<i>E</i>-decenoic acid	up	162	1.91e-08
OHXPGWPVLFPUSM-KLRNGDHRSA-N	3,7,12-Triketo-5beta-cholanoic acid	up	47.63	2.53e-09
YEDUAINPPJYDJZ-UHFFFAOYSA-N	HBT	up	10.13	8.04e-14